Projects per year
Personal profile
Education
- 1982 Taipei Medical College, M.D.
Research Interests
- Hepatitis
- Hepatocellular Carcinoma
- Virology
Experience
- 1990/8~1993/7 Instructor of Medicine, Medical College, National Cheng Kung University (NCKU)
- 1993/8~1996/7 Associate Professor, Medical College, National Cheng Kung University (NCKU)
- 1996/8~present Professor of Medicine, Medical College, National Cheng Kung University (NCKU)
- 1998/8~2000/7 Secretary of Medical Affairs, National Cheng Kung University Hospital (NCKUH)
- 2000/8~2002/7 Director, Department of Clinical Medicine, National Cheng Kung University Hospital (NCKUH)
- 2000/8~2004/7 Director, Institute of Molecular Medicine, Medical College, National Cheng Kung University (NCKU)
- 2000/8~2004/7 Chief, Division of Gastroenterology, National Cheng Kung University Hospital (NCKUH)
- 2003~present Director, Biotechnologic Center of Hepatology, Research and Services Headquarter of National Cheng Kung University
- 2006~present Distinguished Professor of Internal Medicine, Medical College, NCKU
- 2013/8~2017/7 Associate Director, Medical College, National Cheng Kung University Hospital (NCKUH)
Fingerprint
Dive into the research topics where Ting-Tsung Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 20 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Research Output
-
Effectiveness and safety of ledipasvir/sofosbuvir for genotype 2 chronic hepatitis C infection: Real-world experience from Taiwan
Chiu, H. C., Chiu, Y. C., Yang, E. H., Chang, T. T., Chien, S. C., Wu, I. C., Wu, C. H. & Cheng, P. N., 2020, (Accepted/In press) In: Journal of the Formosan Medical Association.Research output: Contribution to journal › Article › peer-review
Open Access -
Genotyping of immune-related loci associated with delayed HBeAg seroconversion in immune-active chronic hepatitis B patients
Liu, W. C., Wu, I. C., Chiu, Y. C., Tseng, K. C., Chen, C. Y., Chiu, H. C., Cheng, P. N. & Chang, T. T., 2020 Apr, In: Antiviral Research. 176, 104719.Research output: Contribution to journal › Article › peer-review
Open Access -
Impact of Immune Checkpoint Inhibitors with or without a Combination of Tyrosine Kinase Inhibitors on Organ-Specific Efficacy and Macrovascular Invasion in Advanced Hepatocellular Carcinoma
Kuo, H. Y., Chiang, N. J., Chuang, C. H., Chen, C. Y., Wu, I. C., Chang, T. T., Tsai, H. M. & Lin, Y. J., 2020 May 1, In: Oncology Research and Treatment. 43, 5, p. 211-220 10 p.Research output: Contribution to journal › Article › peer-review
-
Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma
Chang, T. T. & Ho, C. H., 2020 Aug, In: PloS one. 15, 8 August, e0238251.Research output: Contribution to journal › Article › peer-review
Open Access -
Combined transarterial embolization/ chemoembolization-based locoregional treatment with sorafenib prolongs the survival in patients with advanced hepatocellular carcinoma and preserved liver function: A propensity score matching study
Chien, S. C., Chen, C. Y., Cheng, P. N., Liu, Y. S., Cheng, H. C., Chuang, C. H., Chang, T. T., Chiu, H. C., Lin, Y. J. & Chiu, Y. C., 2019, In: Liver Cancer. 8, 3, p. 186-202 17 p.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus)